## Core Concept
Metoprolol is a beta-1 selective adrenergic receptor blocker used primarily in the treatment of hypertension, angina pectoris, and certain heart failure conditions. Overdose or toxicity of metoprolol can lead to severe bradycardia, hypotension, and potentially life-threatening cardiac complications. Treatment involves supportive care and specific interventions to counteract the beta-blockade effects.

## Why the Correct Answer is Right
In the context of metoprolol toxicity, treatment strategies often involve the use of medications that can counteract the effects of beta-blockade. This includes glucagon, which increases heart rate and contractility; calcium gluconate or chloride, which can help stabilize cardiac membranes; and in some cases, phosphodiesterase inhibitors like milrinone or dobutamine, which can bypass the blocked beta receptors to increase cardiac contractility and heart rate. However, certain medications can worsen the condition or are not directly beneficial.

## Why Each Wrong Option is Incorrect
- **Option A:** Glucagon is used in beta-blocker overdose as it works by increasing cyclic AMP levels, thereby bypassing the beta-adrenergic receptors that are blocked by metoprolol.
- **Option B:** High-dose insulin therapy is sometimes used in the management of beta-blocker toxicity, particularly if there is evidence of decreased cardiac output or severe metabolic derangement. It can help increase cardiac contractility.
- **Option C:** Atropine can be used to treat symptomatic bradycardia associated with beta-blocker overdose, although its effectiveness may be limited in severe cases.
- **Option D:** **Propranolol** is a non-selective beta-blocker. Giving another beta-blocker in the setting of metoprolol toxicity would worsen the blockade and exacerbate the symptoms of toxicity, such as bradycardia and hypotension.

## Clinical Pearl / High-Yield Fact
A key clinical pearl in managing beta-blocker toxicity is the use of glucagon. Glucagon can be particularly effective because it increases intracellular cyclic AMP levels, directly counteracting the effect of beta-blockade. However, it's worth noting that the effectiveness of these treatments can vary, and management should be tailored to the individual patient's presentation and response.

## Correct Answer: D. Propranolol